Release Date: 17/01/19 19:11 Summary: Suspension from Official Quotation Price Sensitive: Yes Download Document 214.48KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%